Literature DB >> 7288265

Evaluation of a rapid immunoturbidimetric assay for opsonic fibronectin in surgical and trauma patients.

T M Saba, W H Albert, F A Blumenstock, G Evanega, F Staehler, E Cho.   

Abstract

A rapid and sensitive method for determination of plasma or serum opsonic fibronectin was developed and evaluated. This is a kinetic immunoturbidimetric assay based on the measurement of an antigen-antibody reaction. Comparison with electroimmunoassay was conducted in septic surgical and trauma patients with opsonic fibronectin deficiency before and after infusion of fibronectin-rich plasma cryoprecipitate. In contrast to the 24 to 48 hr needed for obtaining quantitative determinations by electroimmunoassay, the immunoturbidimetric assay can be accomplished within 10 min and requires only 5 microliters of serum or plasma. The concentration of opsonic fibronectin in plasma is greater than in serum. Plasma anticoagulated with EDTA and supplemented with aprotinin (Trasylol) to inhibit proteolytic activity is the procedure of choice for preparation of samples prior to analysis. The rapid immunoturbidimetric assay has clinical value as a rapid, sensitive, noninvasive means of assessing opsonic fibronectin and indirectly evaluating RES function. Its diagnostic as well as prognostic value with respect to various diseases remains to be carefully studied.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7288265

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  16 in total

1.  Plasma fibronectin concentrations in blood products.

Authors:  J Perttilä; M Salo; O Peltola
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous.

Authors:  Koji Sawada; Ryouki Takahashi; Abbi R Saniabadi; Maiko Ohdo; Takashi Shimoyama
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

3.  Plasma fibronectin and thyroid function.

Authors:  W Graninger; K Pirich; K Derfler; W Waldhäusl
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

4.  Sample collection for determination of plasma fibronectin concentration.

Authors:  P T Toy; M E Reid
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

5.  Fibronectin and Kupffer cell function in fulminant hepatic failure.

Authors:  M Imawari; R D Hughes; C D Gove; R Williams
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

6.  Plasma fibronectin in psoriatic arthritis subgroups.

Authors:  M Cutolo; S Accardo; M A Cimmino; S Rovida
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

7.  Purified fibronectin administration to patients with severe abdominal infections. A controlled clinical trial.

Authors:  P Lundsgaard-Hansen; J E Doran; E Rubli; E Papp; J J Morgenthaler; P Späth
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

8.  Different synovial fluid fibronectin levels in rheumatoid variants.

Authors:  K M Goebel; U Storck; K Krüger; M Schattenkirchner
Journal:  Klin Wochenschr       Date:  1984-08-16

9.  Reversal of fibronectin and opsonic deficiency in patients. A controlled study.

Authors:  T M Saba; F A Blumenstock; D M Shah; J E Kaplan; E Cho; W Scovill; H Stratton; J Newell; M Gottlieb; N Sedransk
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

10.  [Fibronectin].

Authors:  E Klar; D L Heene
Journal:  Klin Wochenschr       Date:  1984-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.